In today’s session Albemarle Corporation (ALB) recorded an unusually high (150) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the October, 2016 put, expecting serious ALB decrease. With 150 contracts traded and 8984 open interest for the Oct, 16 contract, it seems this is a quite bearish bet. The option with symbol: ALB161021P00080000 closed last at: $0.95 or 0% . About 47,978 shares traded hands. Albemarle Corporation (NYSE:ALB) has risen 31.35% since March 11, 2016 and is uptrending. It has outperformed by 25.89% the S&P500.
Analysts await Albemarle Corporation (NYSE:ALB) to report earnings on November, 2. They expect $0.81 EPS, down 10.00% or $0.09 from last year’s $0.9 per share. ALB’s profit will be $90.21M for 25.22 P/E if the $0.81 EPS becomes a reality. After $1.09 actual EPS reported by Albemarle Corporation for the previous quarter, Wall Street now forecasts -25.69% negative EPS growth.
Albemarle Corporation (NYSE:ALB) Ratings Coverage
Out of 11 analysts covering Albemarle Corporation (NYSE:ALB), 8 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 73% are positive. $95 is the highest target while $52 is the lowest. The $75.78 average target is -7.26% below today’s ($81.71) stock price. Albemarle Corporation has been the topic of 23 analyst reports since August 7, 2015 according to StockzIntelligence Inc. On Tuesday, February 23 the stock rating was maintained by JP Morgan with “Neutral”. The stock has “Buy” rating given by Deutsche Bank on Thursday, August 20. Citigroup upgraded the shares of ALB in a report on Monday, November 2 to “Buy” rating. Suntrust Robinson maintained Albemarle Corporation (NYSE:ALB) rating on Thursday, May 12. Suntrust Robinson has “Buy” rating and $85 price target. As per Thursday, May 12, the company rating was maintained by Deutsche Bank. Deutsche Bank maintained the shares of ALB in a report on Friday, August 5 with “Buy” rating. Citigroup maintained Albemarle Corporation (NYSE:ALB) rating on Monday, April 18. Citigroup has “Buy” rating and $76 price target. Deutsche Bank maintained the stock with “Buy” rating in Wednesday, September 16 report. The stock of Albemarle Corporation (NYSE:ALB) earned “Neutral” rating by UBS on Wednesday, November 11. The company was maintained on Tuesday, December 29 by Jefferies.
According to Zacks Investment Research, “Albemarle Corporation is a major producer of fine and performance chemicals including polymer intermediates, cleaning product intermediates and additives, agricultural chemical intermediates, pharmaceutical intermediates, catalysts, brominated flame retardants, bromine chemicals and potassium and chlorine chemicals.”
Insitutional Activity: The institutional sentiment increased to 1.36 in Q2 2016. Its up 0.26, from 1.1 in 2016Q1. The ratio improved, as 31 funds sold all Albemarle Corporation shares owned while 112 reduced positions. 80 funds bought stakes while 115 increased positions. They now own 96.46 million shares or 7.92% less from 104.76 million shares in 2016Q1.
Davenport Limited Liability Corporation has invested 0% of its portfolio in Albemarle Corporation (NYSE:ALB). Daiwa Secs accumulated 2,700 shares or 0% of the stock. Robecosam Ag accumulated 160,000 shares or 1.16% of the stock. Canada Pension Plan Investment Board, a Ontario – Canada-based fund reported 1,910 shares. Twin Tree Mgmt L P holds 0.01% of its portfolio in Albemarle Corporation (NYSE:ALB) for 9,786 shares. Fjarde Ap last reported 32,893 shares in the company. Ubs Asset Americas has 238,984 shares for 0.02% of their US portfolio. Herndon Cap Ltd has 0% invested in the company for 10 shares. Central Asset And Holdg (Hk) Ltd reported 33,700 shares or 2.65% of all its holdings. Cibc Asset Mgmt reported 12,971 shares or 0.01% of all its holdings. Cibc Ww Mkts holds 7,368 shares or 0% of its portfolio. Carroll Financial Assoc holds 240 shares or 0% of its portfolio. Van Eck Assoc has invested 0% of its portfolio in Albemarle Corporation (NYSE:ALB). Fifth Third Comml Bank has invested 0% of its portfolio in Albemarle Corporation (NYSE:ALB). Natixis Asset Mgmt has 10,307 shares for 0.09% of their US portfolio.
Insider Transactions: Since May 12, 2016, the stock had 0 buys, and 5 selling transactions for $5.93 million net activity. $153,353 worth of Albemarle Corporation (NYSE:ALB) was sold by SHERMAN JOHN JR on Thursday, May 12. Another trade for 13,174 shares valued at $992,529 was sold by Juneau Matthew. Shares for $4.16 million were sold by KISSAM LUTHER C IV. 3,564 shares were sold by LaBauve Donald J. Jr., worth $268,514.
Albemarle Corporation is a developer, maker and marketer of specialty chemicals across a range of end markets, including the petroleum refining, consumer electronics, energy storage, construction, automotive, steel and aerospace, lubricants, pharmaceuticals, heating, ventilation, and aluminum finishing. The company has a market cap of $9.10 billion. The Firm operates through three divisions: Performance Chemicals, Refining Solutions and Chemetall Surface Treatment. It has a 17.2 P/E ratio. The Company’s Performance Chemicals segment consists of three product categories: Lithium, Performance Catalyst Solutions and Bromine.
ALB Company Profile
Albemarle Corporation, incorporated on November 24, 1993, is a developer, maker and marketer of specialty chemicals across a range of end markets, including the petroleum refining, consumer electronics, energy storage, construction, automotive, steel and aerospace, lubricants, pharmaceuticals, crop protection, household appliances, heating, ventilation, aluminum finishing, food safety and custom chemistry services. The Firm operates through three divisions: Performance Chemicals, Refining Solutions and Chemetall Surface Treatment.
Another recent and important Albemarle Corporation (NYSE:ALB) news was published by Prnewswire.com which published an article titled: “Albemarle Corporation to release third quarter 2016 earnings results on …” on October 06, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.